Related references
Note: Only part of the references are listed.HuR Mediates Changes in the Stability of AChR β-Subunit mRNAs after Skeletal Muscle Denervation
Olivier R. Joassard et al.
JOURNAL OF NEUROSCIENCE (2015)
β-Adrenergic modulation of skeletal muscle contraction: key role of excitation-contraction coupling
Simeon P. Cairns et al.
JOURNAL OF PHYSIOLOGY-LONDON (2015)
Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment
Andrew G. Engel et al.
LANCET NEUROLOGY (2015)
Absence of α- and β-dystroglycan is associated with Walker-Warburg syndrome
Moniek Riemersma et al.
NEUROLOGY (2015)
Delayed diagnosis of congenital myasthenia due to associated mitochondrial enzyme defect
Yiran Guo et al.
NEUROMUSCULAR DISORDERS (2015)
Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy
Sophie Nicole et al.
BRAIN (2014)
Mitochondrial myopathies in adults and children: management and therapy development
Robert D. S. Pitceathly et al.
CURRENT OPINION IN NEUROLOGY (2014)
COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina
Juan Arredondo et al.
HUMAN GENETICS (2014)
Terminal Schwann Cells Participate in Neuromuscular Synapse Remodeling during Reinnervation following Nerve Injury
Hyuno Kang et al.
JOURNAL OF NEUROSCIENCE (2014)
Understanding the Process of Fibrosis in Duchenne Muscular Dystrophy
Yacine Kharraz et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Muscle type and fiber type specificity in muscle wasting
Stefano Ciciliot et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Peripheral nerve hyperexcitability with preterminal nerve and neuromuscular junction remodeling is a hallmark of Schwartz-Jampel syndrome
Stephanie Bauche et al.
NEUROMUSCULAR DISORDERS (2013)
Nuclear positioning in muscle development and disease
Eric S. Folker et al.
FRONTIERS IN PHYSIOLOGY (2013)
Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations
I. Wargon et al.
NEUROMUSCULAR DISORDERS (2012)
Molecular Mechanisms and Treatment Options for Muscle Wasting Diseases
Markus A. Rueegg et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
AREsite: a database for the comprehensive investigation of AU-rich elements
Andreas R. Gruber et al.
NUCLEIC ACIDS RESEARCH (2011)
FIBER TYPES IN MAMMALIAN SKELETAL MUSCLES
Stefano Schiaffino et al.
PHYSIOLOGICAL REVIEWS (2011)
Cholinesterases regulation in the absence of ColQ
Severine M. Sigoillot et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Myasthenia and related disorders of the neuromuscular junction
Jennifer Spillane et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
ColQ Controls Postsynaptic Differentiation at the Neuromuscular Junction
Severine M. Sigoillot et al.
JOURNAL OF NEUROSCIENCE (2010)
Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7
D. Lashley et al.
NEUROLOGY (2010)
Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes
Violeta Mihaylova et al.
BRAIN (2008)
Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia
Morgane Stum et al.
HUMAN MOLECULAR GENETICS (2008)
Gene expression of myogenic regulatory factors, nicotinic acetylcholine receptor subunits, and GAP-43 in skeletal muscle following denervation in a rat model
Jianjun Ma et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2007)
The therapy of congenital myasthenic syndromes
Andrew G. Engel
NEUROTHERAPEUTICS (2007)
Spectrum of HSPG2 (perlecan) mutations in patients with Schwartz-Jampel syndrome
Morgane Stum et al.
HUMAN MUTATION (2006)
Characterization of a muscle-specific enhancer in human MuSK promoter reveals the essential role of myogenin in controlling activity-dependent gene regulation
HB Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cholinesterases and the resistance of the mouse diaphragm to the effect of tubocurarine
T Nguyen-Huu et al.
ANESTHESIOLOGY (2005)
The acetylcholine receptor γ-to-ε switch occurs in individual endplates
N Yumoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart
C Marionneau et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse
LM Kimbell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Congenital myasthenic syndromes
D Hantaï et al.
CURRENT OPINION IN NEUROLOGY (2004)
MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction
A Cartaud et al.
JOURNAL OF CELL BIOLOGY (2004)
CaM kinase II-dependent phosphorylation of myogenin contributes to activity-dependent suppression of nAChR gene expression in developing rat myotubes
HB Tang et al.
CELLULAR SIGNALLING (2004)
Dystroglycan glycosylation and its role in matrix binding in skeletal muscle
PT Martin
GLYCOBIOLOGY (2003)
Two different heparin-binding domains in the triple-helical domain of ColQ, the collagen tail subunit of synaptic acetylcholinesterase
P Deprez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions
J Minic et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice
E Arikawa-Hirasawa et al.
NATURE NEUROSCIENCE (2002)
Learning gene functional classifications from multiple data types
P Pavlidis et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Induction, assembly, maturation and maintenance of a postsynaptic apparatus
JR Sanes et al.
NATURE REVIEWS NEUROSCIENCE (2001)
The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane
C Jacobson et al.
JOURNAL OF CELL BIOLOGY (2001)
Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)
S Nicole et al.
NATURE GENETICS (2000)
Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells
AG Ridgeway et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
